Clinical Trial Update: Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated bortezomib and rituximab in mantle cell lymphoma patients who had prior stem cell transplantation; results have been posted (completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)
• Rituximab (rituximab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2022-02-04